Global Epilepsy Market Size to grow USD 4.7 Billion by 2030 | CAGR of 8.35%: Spherical Insights
March 20, 2023 16:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, March 20, 2023 (GLOBE NEWSWIRE) -- Global Epilepsy Market worth $4.70 Billion by 2030 According to a research report published by Spherical Insights &...
Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing
March 03, 2020 08:00 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif. and HINXTON, United Kingdom, March 03, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an industry leader in microfluidics technology, and Next Gen...
Hemispherx Biopharma Reports Evidence Based Clinical Potential of a Natural Interferon (IFN) -- Alpha for Infection Control and Treatment of Drug Resistant H7N9 Influenza Virus
January 07, 2014 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Jan. 7, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") today announced publication of an article entitled "Emergence of a novel drug...
Immunitor Releases Positive Results of TB Immunotherapy From Its Second Clinical Site
January 24, 2011 04:43 ET
|
Immune Network Ltd
VANCOUVER, British Columbia, Jan. 24, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd., (Pink Sheets:IMMFF) a company in the business of development and commercialization of immune therapies, announced...